Arno Andrew 4
4 · Oncocyte Corp · Filed Jun 27, 2023
Insider Transaction Report
Form 4
Arno Andrew
Director
Transactions
- Award
Option to Purchase Common Stock
2023-06-23+135,000→ 135,000 totalExercise: $0.20Exp: 2033-06-23→ Common Stock (135,000 underlying) - Award
Common Stock, no par value
2023-06-23+30,000→ 703,133 total
Holdings
- 156,084(indirect: See footnote)
Common Stock, no par value
- 156,084(indirect: See footnote)
Common Stock, no par value
Footnotes (4)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]These shares of the Issuer's common stock, no par value ("Common Stock"), are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and in such capacity has the right to vote and dispose of securities held by JBA.
- [F3]These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and in such capacity has the right to vote and dispose of securities held by MJA.
- [F4]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.